Malme KB, Stene-Johansen K, Klundby I, Backe Ø, Foshaug T, Greve MH, Pihl CM, Finbråten AK, Dalgard O, Midgard H(2024) Virologic Response and Reinfection Following HCV Treatment among Hospitalized People Who Inject Drugs: Follow-Up Data from the OPPORTUNI-C Trial Viruses, 16(6) DOI 10.3390/v16060858, PubMed 38932151
Midgard H, Malme KB, Finbråten AK, Dalgard O(2024) Treatment completion and SVR in the context of HCV elimination: Time to let go of the reins? Clin Infect Dis(in press) DOI 10.1093/cid/ciae298, PubMed 38824443
Druckrey-Fiskaaen KT, Vold JH, Madebo T, Midgard H, Dalgard O, Leiva RA, Fadnes LT, INTRO-HCV Study Group(2024) Liver stiffness and associated risk factors among people with a history of injecting drugs: a prospective cohort study Subst Abuse Treat Prev Policy, 19(1), 21 DOI 10.1186/s13011-024-00603-z, PubMed 38532435